Latest News

April 2008

Day : 25

RANBAXY RECEIVES FINAL US FDA APPROVAL TO MANUFACTURE AND MARKET CETIRIZINE HYDROCHLORIDE ORAL SOLUTION

Day : 22

RANBAXY AND ORCHID ANNOUNCE STRATEGIC BUSINESS ALLIANCE

Q1 2008 GLOBAL SALES AT USD 409 MN (RS 16,231 MN), + 15%

Day : 15

RANBAXY AND ASTRAZENECA REACH AGREEMENT IN ESOMEPRAZOLE PATENT LITIGATION

Day : 9

RANBAXY AND DBT COLLABORATE IN THE AREA OF NDDR

Day : 8

RANBAXY BECOMES FIRST FOREIGN GENERIC COMPANY TO DEVELOP A GENERIC PRODUCT INDEPENDENTLY OUTSIDE JAPAN AND RECEIVE AUTHORISATION FROM MHLW - JAPAN

Day : 3

RANBAXY LAUNCHES WORLDS FIRST BIO-GENERIC RECOMBINANT INJECTIBLE FOR THE TREATMENT OF OSTEOPOROSIS IN INDIA

March 2008

Day : 28

RANBAXY ANNUAL AUDITED RESULTS FOR YEAR 2007

Day : 18

RANBAXY TO INTRODUCE INERSAN BRAND IN INDIA AND NEPAL

February 2008

Day : 19

RANBAXY BOARD CLEARS SCHEME OF DE-MERGER OF NEW DRUG DISCOVERY RESEARCH UNIT

Read more news from Ranbaxy >